Neuroendocrine Tumor Treatment Market Report

Global and Region Neuroendocrine Tumor Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：230
  • REPORT CODE：GMM947505
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Neuroendocrine Tumor Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Neuroendocrine Tumor Treatmentmarket, defines the market attractiveness level of Neuroendocrine Tumor Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Neuroendocrine Tumor Treatment industry, describes the types of Neuroendocrine Tumor Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuroendocrine Tumor Treatment market and the development prospects and opportunities of Neuroendocrine Tumor Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuroendocrine Tumor Treatment market in Chapter 13.

    By Player:

    • Progenics Pharmaceuticals Inc

    • Tarveda Therapeutics

    • Novartis AG

    • Hutchinson Medipharma Limited

    • Exelixis Inc

    • Ispen

    • Advanced Accelerator Applications

    • Dauntless Pharmaceuticals Inc

    By Type:

    • Everolimus

    • Sunitinib

    • Lu-Dotatate

    • Lanreotide

    • Octreotide

    By End-User:

    • Hospitals

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Neuroendocrine Tumor Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Neuroendocrine Tumor Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Neuroendocrine Tumor Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Neuroendocrine Tumor Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Neuroendocrine Tumor Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Neuroendocrine Tumor Treatment Consumption (2017-2022)

    • 7.2 United States Neuroendocrine Tumor Treatment Consumption (2017-2022)

    • 7.3 Europe Neuroendocrine Tumor Treatment Consumption (2017-2022)

    • 7.4 China Neuroendocrine Tumor Treatment Consumption (2017-2022)

    • 7.5 Japan Neuroendocrine Tumor Treatment Consumption (2017-2022)

    • 7.6 India Neuroendocrine Tumor Treatment Consumption (2017-2022)

    • 7.7 South Korea Neuroendocrine Tumor Treatment Consumption (2017-2022)

    8 Region and Country-wise Neuroendocrine Tumor Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Neuroendocrine Tumor Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Neuroendocrine Tumor Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Neuroendocrine Tumor Treatment Consumption Forecast (2022-2028)

    • 8.4 China Neuroendocrine Tumor Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Neuroendocrine Tumor Treatment Consumption Forecast (2022-2028)

    • 8.6 India Neuroendocrine Tumor Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Neuroendocrine Tumor Treatment Consumption Forecast (2022-2028)

    9 Global Neuroendocrine Tumor Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Neuroendocrine Tumor Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Everolimus Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Sunitinib Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Lu-Dotatate Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Lanreotide Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Octreotide Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neuroendocrine Tumor Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Neuroendocrine Tumor Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Neuroendocrine Tumor Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Everolimus Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Sunitinib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Lu-Dotatate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Lanreotide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Octreotide Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Neuroendocrine Tumor Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Neuroendocrine Tumor Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Neuroendocrine Tumor Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Neuroendocrine Tumor Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Neuroendocrine Tumor Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Neuroendocrine Tumor Treatment Market Competitive Analysis

    • 14.1 Progenics Pharmaceuticals Inc

      • 14.1.1 Progenics Pharmaceuticals Inc Company Details

      • 14.1.2 Progenics Pharmaceuticals Inc Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Progenics Pharmaceuticals Inc Neuroendocrine Tumor Treatment Product and Service

    • 14.2 Tarveda Therapeutics

      • 14.2.1 Tarveda Therapeutics Company Details

      • 14.2.2 Tarveda Therapeutics Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Product and Service

    • 14.3 Novartis AG

      • 14.3.1 Novartis AG Company Details

      • 14.3.2 Novartis AG Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis AG Neuroendocrine Tumor Treatment Product and Service

    • 14.4 Hutchinson Medipharma Limited

      • 14.4.1 Hutchinson Medipharma Limited Company Details

      • 14.4.2 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Product and Service

    • 14.5 Exelixis Inc

      • 14.5.1 Exelixis Inc Company Details

      • 14.5.2 Exelixis Inc Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Exelixis Inc Neuroendocrine Tumor Treatment Product and Service

    • 14.6 Ispen

      • 14.6.1 Ispen Company Details

      • 14.6.2 Ispen Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Ispen Neuroendocrine Tumor Treatment Product and Service

    • 14.7 Advanced Accelerator Applications

      • 14.7.1 Advanced Accelerator Applications Company Details

      • 14.7.2 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Product and Service

    • 14.8 Dauntless Pharmaceuticals Inc

      • 14.8.1 Dauntless Pharmaceuticals Inc Company Details

      • 14.8.2 Dauntless Pharmaceuticals Inc Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Dauntless Pharmaceuticals Inc Neuroendocrine Tumor Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Neuroendocrine Tumor Treatment

    • Figure Neuroendocrine Tumor Treatment Picture

    • Table Global Neuroendocrine Tumor Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neuroendocrine Tumor Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neuroendocrine Tumor Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Neuroendocrine Tumor Treatment Consumption by Country (2017-2022)

    • Figure United States Neuroendocrine Tumor Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Neuroendocrine Tumor Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Neuroendocrine Tumor Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Neuroendocrine Tumor Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Neuroendocrine Tumor Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neuroendocrine Tumor Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Neuroendocrine Tumor Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Neuroendocrine Tumor Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neuroendocrine Tumor Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Neuroendocrine Tumor Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neuroendocrine Tumor Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neuroendocrine Tumor Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neuroendocrine Tumor Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Everolimus Consumption and Growth Rate (2017-2022)

    • Figure Global Sunitinib Consumption and Growth Rate (2017-2022)

    • Figure Global Lu-Dotatate Consumption and Growth Rate (2017-2022)

    • Figure Global Lanreotide Consumption and Growth Rate (2017-2022)

    • Figure Global Octreotide Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Everolimus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sunitinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lu-Dotatate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lanreotide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Octreotide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Neuroendocrine Tumor Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Neuroendocrine Tumor Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Progenics Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Progenics Pharmaceuticals Inc Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Progenics Pharmaceuticals Inc Neuroendocrine Tumor Treatment Product and Service

    • Table Tarveda Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Tarveda Therapeutics Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tarveda Therapeutics Neuroendocrine Tumor Treatment Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Neuroendocrine Tumor Treatment Product and Service

    • Table Hutchinson Medipharma Limited (Foundation Year, Company Profile and etc.)

    • Table Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Product and Service

    • Table Exelixis Inc (Foundation Year, Company Profile and etc.)

    • Table Exelixis Inc Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exelixis Inc Neuroendocrine Tumor Treatment Product and Service

    • Table Ispen (Foundation Year, Company Profile and etc.)

    • Table Ispen Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ispen Neuroendocrine Tumor Treatment Product and Service

    • Table Advanced Accelerator Applications (Foundation Year, Company Profile and etc.)

    • Table Advanced Accelerator Applications Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Accelerator Applications Neuroendocrine Tumor Treatment Product and Service

    • Table Dauntless Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Dauntless Pharmaceuticals Inc Neuroendocrine Tumor Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dauntless Pharmaceuticals Inc Neuroendocrine Tumor Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US